FDA OKs Simponi for Pediatric Ulcerative Colitis

The TNF-alpha inhibitor is indicated to treat children weighing at least 15 kg living with moderately to severely active ulcerative colitis.
Medscape Medical News

Source link : https://www.medscape.com/viewarticle/fda-oks-simponi-pediatric-ulcerative-colitis-2025a1000r5u?src=rss

Author :

Publish date : 2025-10-08 16:02:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

FDA OKs Simponi for Pediatric Ulcerative Colitis

Why everything you thought you knew about your immune system is wrong

Federal Government Shutdown Grinds Into a Second Week, but Quiet Talks Emerging

Related Posts

More Muscle, Less Visceral Fat Tied to Younger Brain Age, Study Suggests

Responses to Patient Expectations Affect Physicians’ Income

EDs Lack Diagnostic Accuracy for Altered Mental Status

Lifestyle Medicine Moves From Movement to Mainstream

ASTRO Issues First Guideline on Gastric Cancer Radiotherapy

Ward to Runway? The Power Suits Supporting Patients & HCPs

More Muscle, Less Visceral Fat Tied to Younger Brain Age, Study Suggests

Responses to Patient Expectations Affect Physicians’ Income

EDs Lack Diagnostic Accuracy for Altered Mental Status

Lifestyle Medicine Moves From Movement to Mainstream

ASTRO Issues First Guideline on Gastric Cancer Radiotherapy

Ward to Runway? The Power Suits Supporting Patients & HCPs

Societies Lay Groundwork for EP Procedures Outside Hospital

The Art of Managing Upward for Young Physicians

Categories

Archives